Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 47, Issue 11

Issues

Biochemical role of intravaginal sildenafil citrate as a novel antiabortive agent in unexplained recurrent spontaneous miscarriage: first clinical study of four case reports from Egypt

Mohamed El-Far
  • Division of Biochemistry, Department of Chemistry, Faculty of Science, Mansoura University, Mansoura, Egypt
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Abd El-Gawad El-Motwally / Ikbal Abou Hashem / Nadia Bakry

Abstract

Background: Many factors have been implicated in the pathogenesis of unexplained recurrent spontaneous miscarriage (URSM).

Methods: The objective of this preliminary clinical study was to verify whether intravaginal sildenafil citrate tablets (25 mg intravaginally, 4 times/day for 24 days) are effective as a novel treatment of threatened miscarriage in patients with a history of URSM (n=4). We also evaluated changes in the concentrations of some antioxidants, the percent expression of cells positive for tumor necrosis factor-α (TNF-α), CD56+T-cells [CD3+CD56+ natural killer cells (NKT cells) (cluster differentiation 3, 56 NKT cells)], which express one of the NK cell markers, and uterine artery pulsatility index (PI). We compared these results with healthy women in their first trimester of pregnancy (FTP n=4).

Results: Sildenafil improved the measured antioxidants concentrations [total antioxidant capacity (TAC), glutathione S-transferase (GSH-S-T) and catalase (CAT), superoxide dismutase (SOD)], and improved oxidative stress by reducing malondialdehyde (MDA) and nitric oxide (NO) in the four patients under investigation. The improvement in antioxidants was close to concentrations seen in women in their FTP. The four patients had progressed to their third trimester of pregnancy using this novel application. The percentage of [CD3+CD56+ NKT cells] and TNF-α in peripheral blood was higher in URSM patients compared to women in their FTP. However, concentrations were greatly reduced and improved after sildenafil administration. We demonstrated that intravaginal sildenafil citrate tablets can reduce vasoconstriction by increasing blood flow through relaxation of uterine arteries as indicated from measured PI in URSM patients.

Conclusions: We conclude that intravaginal sildenafil citrate tablets used as suppositories might be a novel, interesting, safe antiabortive option in the treatment of threatened miscarriage in patients with a history of URSM. We are the first to report this novel clinical application in four case reports in Egypt.

Clin Chem Lab Med 2009;47:1433–8.

Keywords: antiabortive agent; antioxidants; intravaginal sildenafil; tumor necrosis factor-α; unexplained recurrent spontaneous abortion

About the article

Corresponding author: Prof. Dr. Mohamed El-Far, Head Division of Biochemistry, Faculty of Science, Mansoura University, Mansoura, Egypt Phone: +20 502248348, Fax: +20 502246254,


Received: 2009-06-02

Accepted: 2009-07-24

Published in Print: 2009-11-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 47, Issue 11, Pages 1433–1438, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2009.311.

Export Citation

©2009 by Walter de Gruyter Berlin New York.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Maram Hussein Zahra, Tarek A.R. Salem, Bishoy El-Aarag, Nermeen Yosri, Samah EL-Ghlban, Kholoud Zaki, Amel H. Marei, Aida Abd El-Wahed, Aamer Saeed, Alfi Khatib, Mohamed F. AlAjmi, Abdulrahman M. Shathili, Jianbo Xiao, Shaden A. M. Khalifa, and Hesham R. El-Seedi
Molecules, 2019, Volume 24, Number 13, Page 2495
[2]
Mohamed El-Far, Neven Salah, Alaa Essam, Amira Abd El-Azim, Mahmoud Karam, and Ibrahim M El-Sherbiny
Nanomedicine, 2019, Volume 14, Number 5, Page 553
[3]
Mohamed El-Far, Neven Salah, Alaa Essam, Amira O Abd El-Azim, and Ibrahim M El-Sherbiny
Nanomedicine, 2018
[4]
Ghada M. Mansour, Sherif H. Hussein, Rasha M. Abd El Hady, Haitham F. Mohammed, Magdy M. Abd El Gawad, Ahmed I. Abou Gabal, Rania M. Al-Awadhy, and Mohamed El Saied
The Journal of Maternal-Fetal & Neonatal Medicine, 2018, Page 1
[5]
Heba M. Aboud, Amira H. Hassan, Adel A. Ali, and Abdel-Razik H. Abdel-Razik
Drug Delivery, 2018, Volume 25, Number 1, Page 1328
[6]
Monika Kniotek and Agnieszka Boguska
Journal of Immunology Research, 2017, Volume 2017, Page 1
[7]
Mohamed Abdel Razik, Seham El-Berry, Ahmed El-Nezamy, Ahmed Saad, and Ahmed Abdel Wahab
Gynecological Endocrinology, 2017, Volume 33, Number 3, Page 199
[8]
Taymour Mostafa
Sexual Medicine Reviews, 2017, Volume 5, Number 2, Page 170
[9]
R.L. Luna, A.K.S. Nunes, A.G.V. Oliveira, S.M.R. Araujo, A.J.J.M. Lemos, S.W.S. Rocha, B.A. Croy, and C.A. Peixoto
Placenta, 2015, Volume 36, Number 10, Page 1122
[10]
Salah Sheweita, Basant Salama, and Mostafa Hassan
Toxicology Reports, 2015, Volume 2, Page 933
[11]
H.H. Baghdadi, A. Allam, and S.A. Sheweita
Journal of Taibah University Medical Sciences, 2013, Volume 8, Number 3, Page 151
[12]
Srinivasan Shanmugam, Young-Hun Kim, Jeong-Hee Park, Ho Taek Im, Young Taek Sohn, Kyeong Soo Kim, Yong-Il Kim, Chul Soon Yong, Jong Oh Kim, Han-Gon Choi, and Jong Soo Woo
Drug Development and Industrial Pharmacy, 2014, Volume 40, Number 6, Page 803
[13]
Mohamed El-Far, Mohamed Elshal, Manar Refaat, and Ibrahim M. El-Sherbiny
Drug Development and Industrial Pharmacy, 2011, Volume 37, Number 12, Page 1481
[14]
Robert A Kloner, Gary Comstock, Laurence A Levine, Steven Tiger, and Vera J Stecher
Expert Opinion on Pharmacotherapy, 2011, Volume 12, Number 15, Page 2297

Comments (0)

Please log in or register to comment.
Log in